Clinical trial
UK HER2 Positive Breast Cancer Productivity & Utility Non-Interventional Study (PURPOSE)
NCT03099200 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- UK HER2 Positive Breast Cancer Productivity & Utility Non-Interventional Study (PURPOSE)
- Lead sponsor
- Hoffmann-La Roche
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 12, 2016
- Completion date
- March 17, 2017
- Enrollment
- 300 (actual)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.